Dr. David Spigel: What are the most promising targeted therapy approaches in lung cancer for the next few years?

Info
Chat in Diretta Commenti

Medicina, #afatinib, #alk, #cancer, #cancergrace, #cannon, #center, #david, #egfr, #grace, #gracecast, #immunotherapy, #inhibitor, #kras, #ldk, #mek, #met, #pd1, #pdl1, #sarah, #spigel

Featured This Week
Spreaker's Prime Shows
Staff Picks
Crime
This NFL life 🏈
Scopri di più

Dr. David Spigel, Sarah Cannon Cancer Center, offers his perspective on the agents he feels most likely to become clinical tools against lung cancer over the next few years.

Autore

cancerGRACE Meetings 2 followers Follow